GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in infants and young children. In addition, RSV causes significant morbidity and mortality in hospitalized elderly and immunocompromised patients. Currently, only palivizumab, a monoclonal antibody against the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Perron, Michel, Stray, Kirsten, Kinkade, April, Theodore, Dorothy, Lee, Gary, Eisenberg, Eugene, Sangi, Michael, Gilbert, Brian E., Jordan, Robert, Piedra, Pedro A., Toms, Geoffery L., Mackman, Richard, Cihlar, Tomas
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4776015/
https://ncbi.nlm.nih.gov/pubmed/26666922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01497-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados